共 338 条
- [1] Akhtar W(2016)The therapeutic journey of pyridazinone Eur J Med Chem 123 256-281
- [2] Shaquiquzzaman M(2012)Combinatorial drug therapy for cancer in the post-genomic era Nat Biotechnol 30 679-692
- [3] Akhter M(2002)The proteasome: a novel target for cancer chemotherapy Leukemia. 16 433-443
- [4] Verma G(2015)A mini review on biological activities of pyridazinone derivatives as antiulcer, antisecretory, antihistamine and particularly against histamine H3R Mini-Rev Med Chem 14 1093-1103
- [5] Khan MF(2006)Manipulating the apoptotic pathway: potential therapeutics for cancer patients Br J Clin Pharmacol 76 381-395
- [6] Alam MM(2014)Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress Antioxid Redox Signal 21 2271-2285
- [7] Al-Lazikani B(2017)Enhanced degradation of misfolded proteins promotes tumorigenesis Cell Rep 18 3143-3154
- [8] Banerji U(2018)Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones Cell Oncol 41 623-636
- [9] Workman P(2015)New platelet aggregation inhibitors based on pyridazinone moiety Eur J Med Chem 94 113-122
- [10] Almond JB(2011)Inhibition of proteasome deubiquitinating activity as a new cancer therapy Nat Med 17 1636-1640